![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 47, 44980-44987, November 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, July 31, 2002, and in revised form, September 16, 2002
The interaction of cationic liposomes with
supercoiled plasmid DNA results in a major rearrangement of each
component to form compact multilamellar structures comprised of
alternating layers of two-dimensional arrays of DNA sandwiched between
lipid bilayers. Fluorescence resonance energy transfer was used to
estimate the distance of closest approach of DNA to the lipid bilayers
in these complexes. The effect of several compositional variables on
this distance, including the ratio of cationic lipid to DNA, and the charge density, intrinsic curvature, and fluidity of the lipid bilayer
were examined. Additionally, the effect of ionic strength was studied.
For complexes prepared at or above a 3:1 charge ratio (+/ The use of cationic lipids to deliver DNA into cells has received
considerable attention for applications in gene therapy (1-3).
Condensation of negatively charged DNA into cationic lipid-DNA complexes (CLDCs)1 is thought
to aid in the delivery of the DNA to the cell nucleus by protecting it
from enzymatic degradation in extracellular compartments, facilitating
binding to the negatively charged cell surface and aiding in
penetration of DNA into the cytosol (4). Numerous studies have
suggested that the efficiency of this delivery process is
related in a still ill-defined way to a variety of physical and
chemical properties of the CLDC (5-17). Most notably, the colloidal
properties and composition of the CLDCs appear to have major effects on
transfection efficiency both in vitro (5) and in
vivo (18).
Given the lack of clear structure/function correlations, a significant
effort has been put into the study of the structures that result from
mixing cationic liposomes with DNA. The formation of CLDCs appears to
involve initial DNA-induced aggregation of the cationic liposomes
followed by vesicle rupture and fusion (6, 16, 19-22), the result of
which is a fairly heterogeneous distribution of particles in terms of
shape and size. Qualitatively, these particles typically appear
globular in nature when cationic lipids are present in charge excess
and are often observed to have tubular strands protruding from the
particle surface when DNA is present in charge excess (6). On a smaller
scale, highly ordered lamellar arrays composed of alternating stacks of
DNA and lipid bilayers are observed in these complexes by cryoelectron microscopy (6, 8, 9, 22-24) and small angle x-ray scattering (10, 14,
15, 25). The lamellar spacing appears to be a function of the type of
lipid used (14), the ratio of cationic lipid to DNA (6), and the
solution conditions (14). In addition to these lamellar arrays,
nonlamellar structures have been observed by cryo-EM (8, 9) and SAXS
(8, 15), by changing the intrinsic curvature of the membrane or its
flexibility. Although these nonlamellar structures have been proposed
to facilitate more efficient delivery of DNA, presumably because of
their ability to cause greater disruption of endosomal membranes (26),
increased transgene expression is not always observed for these systems (6, 27, 28).
Although cryo-EM and SAXS can provide significant detail about the
structure of CLDCs, the conditions for obtaining measurements using
these techniques are often considerably different from those used for
transfection. For example, in the case of cryo-EM, the complexes are
flash frozen. Although studies using SAXS have be conducted using
concentrations of lipid and DNA closer to those used for transfection
by employing high energy synchrotron radiation, studies using more
conventional equipment require significantly greater concentrations
(14). Nevertheless, these techniques have provided surprisingly
consistent information regarding the structural organization of CLDCs
that has been shown to agree with statistical thermodynamic models
(29).
Another technique that can potentially provide detailed
information about the spatial organization of cationic lipids and DNA
in CLDCs is fluorescence resonance energy transfer (FRET). Relationships describing the nonradiative transfer of energy from a
donor fluorophore to a two-dimensional array of acceptor fluorophores embedded in a lipid bilayer have been derived (30-32). These
relationships have been used to determine the distance of closest
approach of proteins to membrane surfaces (33-37). We have used this
approach to describe the association of DNA with cationic lipids as a
function of charge ratio as well as membrane composition. The effect of ionic strength on the association of DNA with cationic bilayers has
also been explored. Correlations with measurements of the distance of
closest approach of DNA to the cationic lipid bilayer and the colloidal
size of the complexes are also reported.
Materials--
Supercoiled plasmid DNA (pMB290, >95%
supercoiled) was obtained from Valentis Inc. The lipids
1,2-dioleoyl-3-trimethylammonium-propane (DOTAP),
dimethyldioctadecylammonium bromide (DDAB),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) were obtained from Avanti Polar Lipids (Alabaster, AL). The fluorescent dyes
Hoechst 33258 (HOC),
2-(4,4-difluoro-5,7-diphenyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphoethanolamine (BODIPY-PE), and 2-(4,4-difluoro-5-(4-phenyl-1,3-butadienyl)- 4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine (BODIPY-PC) were obtained from Molecular Probes (Eugene, OR). The Cy3
LabelITTM kit was obtained from Panvera (Madison, WI). All
of the other chemicals were from Fisher.
Preparation of Cationic Lipid-DNA Complexes--
Liposomes were
first prepared by placing the required amount of a chloroform solution
containing cationic lipid as well as DOPE or DOPC and various amounts
of fluorescently labeled lipids in a glass vial and evaporating the
solvent under a stream of nitrogen gas. The resulting lipid film was
then placed under vacuum for a minimum of 2 h before hydrating in
the appropriate Tris buffer with vortexing. After equilibrating at room
temperature for 30 min, the liposomes were extruded 11 times through a
100-nm pore polycarbonate membrane. The liposomes were stored at
4 °C and typically used within 3 days. For fluorescence studies, DNA was first labeled either noncovalently with HOC at a 1:150 dye/bp ratio
or covalently with Cy3 using the manufacturer's instructions at a 1:50
dye:bp ratio. CLDCs were formed by mixing various amounts of DNA with
an equal volume of a cationic liposome solution with stirring for
20 s. The final cationic lipid concentration was 80 µM to maintain DOTAP above its reported critical micelle
concentration of 70 µM (38). The complexes were allowed
to equilibrate for 20 min before performing measurements. All of the
charge ratios are indicated as positive:negative in the text.
Fluorescence Spectroscopic Measurements--
Fluorescence
spectra of CLDCs labeled with either HOC (excitation/emission, 358/462
nm) and BODIPY-PE (536/558 nm) or Cy3 (550/578 nm) and BODIPY-PC
(586/597 nm) were obtained at 25 °C with a
QuantamasterTM spectrofluorometer equipped with a 75-watt
xenon lamp (PTI, Monmouth, NJ) using an excitation and emission
bandwidth of 3 nm. A quartz cuvette (1 cm (ex) × 0.2 cm (em)) was
used for all studies. For studies with HOC, a 370-nm-long pass filter
was used between the sample and the photomultiplier tube. The quantum
yield of HOC-labeled CLDCs was determined using quinine sulfate in 0.1 N H2SO4 as a reference
(Q = 0.7), whereas that of Cy3-labeled CLDCs was
determined using tetramethylrhodamine in methanol as a reference
(Q = 0.68) using Equation 1.
Correction for light scattering was made by subtracting the signal
produced by the unlabeled sample. Corrections for the inner filter
effect were performed using the following equation based on the
Beer- Lambert Law.
Calculation of the Forster Distance for Donor Acceptor
Pairs--
The Förster distance (R0) for
each donor acceptor pair, which represents the distance of half-maximal
transfer efficiency, was determined using the following equation.
Determination of the Distance of Closest Approach for
Donor-labeled DNA and BODIPY-labeled Cationic Lipids--
Assuming
that the approach of a DNA-bound donor fluorophore to the acceptor
labeled lipid bilayer can be modeled as a point donor and an infinite
plane of randomly distributed acceptors, the distance of closest
approach, L, can be obtained from plots of
IDA/ID versus
the surface density, Dynamic Light Scattering--
The samples were prepared in Tris
buffer, pH 7.4, containing either no or 150 mM NaCl that
had been filtered through 0.2-µm polysulfone filters (Gelman
Science). All of the glassware was exhaustively washed with distilled
and deionized water that had been similarly filtered. The measurements
were taken using a light scattering instrument (Brookhaven Instruments
Corp., Holtszille, NY) employing a 50 mW HeNe diode laser ( To determine the distance of closest approach between DNA and the
cationic lipid bilayer in CLDCs using FRET, DNA was labeled with the
minor groove binding dye, HOC, and the lipid bilayer with a
BODIPY-labeled lipid. It has been previously shown that HOC remains
bound in the DNA minor groove when the DNA is condensed with cationic
lipids.2 The lipid label
BODIPY-PE was chosen for several reasons. First, its spectral
properties, e.g. large and environmentally insensitive extinction coefficient (41) and excellent spectral overlap with the HOC
donor, make it applicable for a variety of lipid systems. Second, it is
located in the apolar region of the lipid bilayer (41), which makes its
mobility less sensitive to binding of DNA as shown previously for other
dyes located in the apolar and interfacial regions of the bilayer
(42).
Determination of the Forster Distance--
The excitation and
emission spectra of HOC and BODIPY-PE are shown in Fig.
1. The quantum yield as well as the
wavelength of the emission maximum of HOC in CLDCs has been previously
shown to depend on the type of lipid present as well as the charge
ratio.2 An increase in QD and a blue
shift in the wavelength of emission maximum are generally observed upon
binding to lipids. Thus, R0 was calculated for
each CLDC using individual values of QD and J( FRET Studies with CLDCs--
Binding of HOC-DNA to BODIPY-labeled
cationic lipids results in a decrease in the fluorescence intensity of
HOC and sensitized emission of the BODIPY probe (Fig.
2). For CLDCs composed of DOTAP and DNA,
plots of IDA/ID
versus the density of BODIPY on the bilayer (
The effect of ionic strength on the distance of closest approach was
examined for DOTAP CLDCs. When prepared in the presence of 150 mM NaCl, linear plots of
IDA/ID versus
To verify the measured distances between cationic lipid and DNA using
the approach of Yguerabide (30), we compared the quenching of HOC
fluorescence by BODIPY acceptors with a series of biexponential approximations to theoretical quenching curves for various ratios of
L to R0 (31). The approximations for
various values of L are shown as solid lines in
Fig. 5 and agree with theoretical values
to within 1%. Although the absolute values of L cannot be
obtained from the experimental curves, it can be estimated that 0.5:1
DOTAP CLDCs possess a distance of closest approach slightly less than
47 Å (Fig. 5, diamonds), whereas the distance separating
HOC-DNA and the BODIPY label in DOTAP bilayers is between 35 and 31 Å for 1:1 complexes (Fig. 5, squares). Positively charged 2:1
DOTAP CLDCs produce a value of L corresponding to just under 27 Å, whereas 3:1 complexes produce a value close to 20 Å. These distances are in excellent agreement with values obtained using Equation 5 (compare with Fig. 4).
To further confirm the accuracy of this approach, a Cy3-BODIPY-PC FRET
donor-acceptor pair was used to measure the distance of closest
approach. In this case, the Cy3 donor was covalently attached to the
DNA. The excitation and emission spectra of Cy3 and BODIPY-PC are shown
in Fig. 6. The quantum yield of Cy3 is 0.03, and the area of spectral overlap, J( Determination of the Mean Hydrodynamic Size of CLDCs--
The mean
diameter of the CLDCs was determined by dynamic light scattering as a
function of charge ratio and lipid composition (Fig.
8). For DOTAP CLDCs with or without DOPE
or DOPC, the size gradually increases as the charge ratio is increased
from 0.5:1 to 1:1, with 0.5:1 DOTAP CLDCs having a mean diameter of 150 nm (black bars). Incorporating equimolar amounts of DOPE or
DOPC into CLDCs results in mean diameters that are 10-20% greater
than DOTAP alone for complexes below 1:1 (Fig. 8A,
white and stippled bars, respectively). Complexes
become colloidally unstable between charges ratio of 1:1 and 2:1
because of charge neutralization (13). Above charge neutrality, DOTAP
containing CLDCs show a maximal size at 2:1, with incorporation of
equimolar amounts of DOPE or DOPC having little effect on particle
size. The mean size of DDAB CLDCs is 30-40% greater than DOTAP CLDCs
when prepared below charge neutrality (Fig. 8A,
striped bars). For positively charged CLDCs, DDAB complexes
are four to five times larger than DOTAP CLDCs. Upon increasing the
ionic strength with 150 mM NaCl, DOTAP CLDCs display a
40-50% increase in the hydrodynamic size for complexes prepared at
charge ratios of 2:1 and below (Fig. 8B). In the presence of
150 mM NaCl, charge neutrality in the complexes occurs
between charge ratios of 2 and 3:1 (13). Complexes prepared above 3:1
are four to five times greater in size at the higher ionic
strength.
Fluorescence resonance energy transfer has been used extensively
to estimate the proximity of a variety of proteins to lipid membranes
using the approach described above (33-37). This study represents an
initial attempt to use this technique to obtain high resolution details
about the association of cationic lipids with DNA. Using FRET,
distances between DNA bound donor fluorophore and acceptor embedded in
the apolar regions of the lipid bilayer were found to be reproducible
with standard errors in the estimates typically less than 5% of the
mean. Systematic errors arising from uncertainty in
QD, J( To facilitate interpretation of the physical meaning of the observed
distances between HOC-DNA and the BODIPY-labeled lipid, the theoretical
distance of closest approach was estimated based on the model in Fig.
9. In the model, L, the
distance of closest approach, is related to the distance between the
planes of HOC and BODIPY (Lp), and the
horizontal distance between the dyes is transposed onto the same plane
(LH) by the following simple Pythagorean
geometric relationship,
In this model, HOC is assumed to be regularly distributed around the
circumference of the DNA double helix. Hence, its distance from the
bilayer surface would be the average of distances, which is taken to be
12.5 Å, or the radius of B-form DNA (47). This distance would also be
applicable to Cy3-labeled DNA. The BODIPY probe is expected to be
buried in the apolar region of the bilayer. Because BODIPY is much more
hydrophobic than other commonly used probes such as NBD, its location
in the bilayer is thought to correlate well with the length of the
alkyl chain connecting it to the lipid headgroup (41). Assuming a
thickness of ~4 Å for the interfacial region of the lipid, 0.95 Å/methylene group of the alkyl chain and a length of the BODIPY along
its long axis of 9 Å, the average distance of BODIPY from the bilayer
surface would be ~12 Å (3 + (5 × 0.95) + 9/2). Thus, we can
estimate the closest distance between HOC and BODIPY to be ~25.5
Å.
For DOTAP CLDCs prepared at or above a 3:1 charge ratio in which the
entire DNA is presumably entrapped in multilamellar structures between
the lipid bilayers, the observed distance of closest approach is around
20 Å. The difference between the observed and calculated distances is
slightly greater than the uncertainty introduced by the assumed value
for When DOTAP CLDCs are prepared below 3:1 ratios, the distance between
DNA and lipid becomes significantly greater than 20 Å, manifesting a
maximal distance around 45 Å for 0.5:1 complexes. Xu et al.
(6) have previously shown by density gradient centrifugation that two
distinct types of CLDCs are formed, depending on the ratio of cationic
lipid to DNA when they are mixed. For complexes formed by mixing lipid
and DNA at ratios greater than 3:1, the actual ratio of cationic lipid
to DNA phosphate in the complex saturates at ~3:1 +/
The Structural Organization of Cationic Lipid-DNA Complexes*
§,
¶,
,
, and
**
Department of Pharmaceutical Chemistry, The
University of Kansas, Lawrence, Kansas 66047 and
Valentis,
Inc., Burlingame, California 94010
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
), the
observed distance of closest approach was found to be in agreement with
the intercalation of DNA between lipid bilayers. As the charge ratio
was decreased, a monotonic increase in the distance was observed with a
maximum observed at 0.5:1. Correlations between differences in the
proximity of DNA to the lipid bilayer and the hydrodynamic size of the
complexes were also found. A model based on these observations and
previous reports suggests the formation of discrete populations of
complexes below a charge ratio of 0.5:1 and above 3:1. The structure of
the negatively charged complexes is consistent with DNA extending from
the surface of the particles, whereas those possessing excess positive
charge were multilamellar aggregates with the DNA effectively condensed between lipid bilayers. Complexes between these two states consist of
weighted fractions of these two species.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Here, Q is the quantum yield, I is the
integrated intensity from 400 to 600 nm in the case of HOC and 560 to
620 nm for Cy3, OD is the optical density at the excitation wavelength,
and n is the refractive index of the solution. The D
subscript refers to the donor fluorophore, and the R subscript
indicates the reference fluorophore of known quantum yield.
(Eq. 1)
Where ODex and ODem are the optical
densities at the donor excitation and emission wavelengths, and
lex and lem are half the
pathlengths for the excitation and emission axes, respectively.
(Eq. 2)
Where,
(Eq. 3)
2 is the orientation factor between donor
and acceptor molecules, n is the refractive index of the
medium between donor and acceptor, QD is the
quantum yield of the donor, and J(
) is the overlap
integral of donor emission and acceptor absorption spectra (in units of
M
1 cm
1 nm4) given
by the following equation.
FD(
(Eq. 4)
) and
A(
) are the
donor emission and acceptor extinction at a given wavelength,
, respectively.
, of the acceptor molecules in the lipid
bilayer, where IDA and ID
are the fluorescence intensities of the donor in the presence or
absence of acceptor, respectively. It has been previously shown that
these two values are related by the following equation (30).
where Lapp is the apparent distance of
closest approach and R0 is described in Equation 3. The density of acceptor in the bilayer is determined using the
following relation.
(Eq. 5)
where [A] is the acceptor concentration, [CL]T
is the total lipid concentration in the cationic liposomes, and
a is the average cross-sectional area of the lipid
headgroups. The latter is assumed to be 70 Å for DOTAP (14), (70 + 65)/2 = 67.5 Å for DOTAP:DOPE (39), (70 + 80)/2 = 75 Å for
DOTAP:DOPC (39), and 60 Å for DDAB (40). The value of 2 on the right
side of the equation reflects the fact that the DNA is presumably
sandwiched between two bilayers, effectively doubling the acceptor
concentration. Equation 6 is essentially equivalent to the Stern-Volmer
relationship describing fluorescence quenching, with
(Eq. 6)
representing
the two-dimensional concentration of quencher. It has been previously
demonstrated that when R0/L < 0.6, L = Lapp (30, 31, 35). In
the case where R0/Lapp > 0.6, a correction must be made that takes the following form.
where the correction factor,
(Eq. 7)
, is interpolated from data
presented in Table I of Yguerabide (30). Further verification of
L can be obtained by comparison of donor quenching with
biexponential approximations to theoretical curves derived by Wolber
and Hudson (31).
= ~532 nm). The scattered light was monitored 90° to the incident
beam, and the autocorrelation function was generated by a digital
correlator (BI-9000AT). The data were collected continuously for five
20-s intervals for each sample and averaged. The autocorrelation
function was fit by the method of cumulants to yield the mean diffusion
coefficient of the complexes. The data are reported for a quadratic
fit. The effective hydrodynamic diameter was obtained from the
diffusion coefficient by the Stokes-Einstein equation.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
). Surprisingly, R0 was found to
be 39 ± 1 Å for all CLDCs examined, presumably because of the
compensating effects of increased quantum yields and decreased areas of
spectral overlap (Equation 3). Calculations of
R0 were made assuming a random distribution of
orientations between donor and acceptor (
2 = 2/3). The
refractive index was taken to be 1.4 (35, 37), and
QD and J(
) fell between 0.38 and
0.50 and 7.7 × 1014 and 9.5 × 1014
M
1 cm
1 nm4,
respectively.

View larger version (26K):
[in a new window]
Fig. 1.
Fluorescence excitation (solid
symbols) and emission (open symbols)
spectra of HOC (circles) and BODIPY-PE
(squares).
)
demonstrate a linear dependence of HOC fluorescence intensity on the
density of BODIPY-PE in the cationic bilayer as predicted from Equation 5 (Fig. 3A). The slope of the
line increases as the ratio of DOTAP to DNA is increased, indicating a
closer association of DNA with the lipid bilayer at higher charge
ratios. Similar results are obtained when DNA is complexed with
DOTAP:DOPE, DOTAP:DOPC, and DDAB (Fig. 3, B, C,
and D, respectively). Energy transfer was essentially
completely inhibited upon the addition of a 50-fold molar excess of the
polyanion heparin, which has been previously demonstrated to cause the
release DNA from these complexes (Ref. 43 and data not shown). The
apparent distance of closest approach, Lapp, was
calculated from the slope of the lines using Equation 5 and corrected
as previously described using Equation 7 (30) to obtain the mean
distance of closest approach, L. These data are summarized
in Fig. 4A. At a charge ratio
of 0.5:1, the average distance between DNA and the probe in DOTAP
bilayers is 45 ± 2 Å (black bars). This distance
decreases as the charge ratio is increased to between 19 and 21 Å at
ratios > 2:1. When the charge density of DOTAP bilayers is
reduced by incorporating equimolar amounts of DOPE or DOPC, similar
trends in the distance of closest approach as a function of CLDC charge
ratio are observed (Fig. 4A, white and
stippled bars, respectively). Comparison with a second
cationic lipid (DDAB) again demonstrates a similar trend in the
distance of closest approach (Fig. 4A, striped
bars). The distance of closest approach appears to be
significantly greater in DDAB compared with DOTAP CLDCs, however. For
DDAB CLDCs below charge neutrality the distance is 52 ± 3 Å,
whereas those above charge neutrality possess a distance of 24 ± 2 Å.

View larger version (19K):
[in a new window]
Fig. 2.
Fluorescence emission spectra of 3:1 +/
DOTAP:DNA labeled with HOC at a ratio of 1 dye (150 bp, solid
squares), BODIPY-PE at a ratio of 1 dye (300 lipids,
open squares) and both HOC and BODIPY-PE
(triangles). The DOTAP concentration was 80 µM.

View larger version (21K):
[in a new window]
Fig. 3.
Representative quenching profiles for HOC-DNA
in CLDCs containing increasing amounts of BODIPY-PE at charge ratios of
0:5:1 +/
(diamonds), 1:1 (squares),
2:1 (triangles), and 3:1
(circles). A, DOTAP CLDCs.
B, DOTAP:DOPE CLDCs. C, DOTAP:DOPC CLDCs.
D, DDAB CLDCs. E, DOTAP CLDCs with 150 mM NaCl. Solid lines represent linear fits to
Equation 5. The data for 4:1 and 5:1 ± CLDCs are not shown
because they typically overlap with the data for 3:1 +/
CLDCs.

View larger version (26K):
[in a new window]
Fig. 4.
Calculated values of the distance of closest
approach of HOC-DNA to BODIPY-PE in CLDCs as a function of charge
ratio. The values were calculated from data in Fig. 3 using
Equations 5 and 7. The data represent the averages and standard errors
for at least three replicates. A, DOTAP (solid
bars), DOTAP:DOPE (open bars), DOTAP:DOPC
(stippled bars), and DDAB (striped bars).
B, DOTAP, 10 mM Tris (solid bars),
and DOTAP, 10 mM Tris, 150 mM NaCl (open
bars).
are still observed (Fig. 3E), and a similar dependence
of the slope on the on the charge ratio of the complex is still present
(Fig. 4B). For DOTAP CLDCs prepared below a charge ratio of
3:1 +/
, increasing the ionic strength significantly increases the
distance of closest approach by as much as 9 Å (Fig. 4B).
At charge ratios above 3:1 +/
, the distance is not affected by the
increased ionic strength.

View larger version (20K):
[in a new window]
Fig. 5.
Comparison of HOC quenching to biexponential
approximations of theoretical curves for energy transfer in two
dimensions derived by Wolber and Hudson (31). The solid
lines represent theoretical curves for various values of
L in Å as indicated to the right of the graph.
The data points represent typical HOC quenching in DOTAP CLDCs at
various charge ratios. 0:5:1 +/
(diamonds), 1:1
(squares), 2:1 (triangles), and 3:1
(circles).
), is 3.5 × 1015 M
1 cm
1
nm4. Assuming
2 to be 2/3 and the refractive
index to be 1.4, R0 is calculated to be 31 ± 1 Å. As seen with the HOC-BODIPY-PE pair, Cy3 fluorescence is
decreased as the density of BODIPY-PC is increased in the DOTAP bilayer
(Fig. 7). For calculation of the distance
of closest approach for this FRET pair using Equations 5 and 7 above,
we obtain a value of 21 ± 2 Å. This is in very good agreement
with the value of 19 ± 1 Å obtained using the HOC-BODIPY-PE pair
(Fig. 4).

View larger version (28K):
[in a new window]
Fig. 6.
Fluorescence excitation (solid
symbols) and emission (open symbols)
spectra of Cy3 (circles) and BODIPY-PC
(squares).

View larger version (10K):
[in a new window]
Fig. 7.
Representative quenching profile of Cy3-DNA
in 3:1 +/
DOTAP CLDCs. The solid line represents
the linear fit to Equation 5.

View larger version (20K):
[in a new window]
Fig. 8.
Hydrodynamic size of CLDCs determined by
DLS. The data represent the means and standard errors of three
separate measurements. A, DOTAP (solid bars),
DOTAP:DOPE (open bars), DOTAP:DOPC (stippled
bars), and DDAB (striped bars). B, DOTAP, 10 mM Tris (solid bars) and DOTAP, 10 mM Tris, 150 mM NaCl (open
bars).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
), and
2,
however, may influence absolute values of the observed distances. These
errors would be expected to effect each system studied similarly. Thus,
comparisons between different CLDCs should still be valid. In
determining QD and J(
), the error
was less than 3%. The greatest degree of uncertainty arises from the
inability to measure
2. It is typical to assume a value
of 2/3, which assumes a random orientation between the donor and
acceptor fluorophores. In general, the error introduced by assuming
2 to be 2/3 is ~10% when donor-acceptor pairs possess
anisotropy values less than 0.3 (44). This has been shown to be the
case for BODIPY in several bilayers of differing fluidity (41) and HOC
bound to DNA (45).
For studies of the distance of a particular group on a protein
from the lipid bilayer, the values of LH have
been necessary for calculations of L because the protein is
often embedded in the lipid bilayer resulting in exclusion of the lipid
dye from regions directly beneath the donor. In the case of CLDCs, the DNA can be assumed to not significantly penetrate the bilayer. Recent
evidence from molecular dynamics simulations suggests that lipids with
zwitterionic headgroups can, in fact, interact directly with the
negatively charged DNA phosphates (46) suggesting that LH is effectively 0. Therefore L
represents the vertical distance between the donor and acceptor
fluorophores.
(Eq. 8)

View larger version (44K):
[in a new window]
Fig. 9.
Model to estimate the distance of closest
approach of HOC to the lipid bilayer as described under
"Discussion."
2. Alternatively, the distance may be expected to
decrease based on the significant amount of bound water displaced from
the lipid-DNA interface upon interaction (17, 48). The radius of B-form DNA in condensed phases has been estimated to be closer to 10 Å, which
would bring our estimate of the closest possible distance to 23 Å. The
remaining discrepancy could be accounted for by displacement of bound
water from the lipid interface.
. Likewise, for
CLDCs formed by mixing lipid and DNA at ratios below 0.5:1, the actual
ratio of cationic lipid complexed to DNA in the particles is typically
found to be 0.5:1 even at the lower charge ratios. In each case the
complexes exist in the presence of unassociated lipid or DNA,
respectively. Because we are measuring average values of L,
it seems most probable that measured values of L in
complexes formed between charge ratios of 0.5 and 3:1 represent the
weighted average of L for these two types of complexes.
Proposed models for these two complexes are shown in Fig.
10. For the negatively charged CLDCs,
the observed distance of ~45 Å would arise from the average distance
of closely associated DNA within the multi-lamellar particles and more
loosely associated DNA molecules at the particle surface. Because the localization of DNA in these negatively charged CLDCs is more heterogeneous, with DNA presumably entrapped between lipid bilayers and
at the particles surface, a greater degree of uncertainty is present in
the measured distance of closest approach of DNA to the bilayer. This
is due to the method used to calculate the two-dimensional density of
the BODIPY acceptor molecules in the membrane based on the model
presented in Fig. 9. Nevertheless, this model is supported by previous
observations of the accessibility of DNA in the CLDCs to nucleases (28,
49-51) and intercalating dyes (21, 49, 52, 53) as well as the fact
that complexes prepared at these charge ratios possess a negatively
charged surface as assessed by measuring the zeta potential of the
particle (13, 17, 19, 28). Additionally, cryo-EM of negatively charged complexes have described particles possessing what are presumably DNA
"spikes" protruding from their surface similar to the model proposed in Fig. 10 (6). Positively charged CLDCs contain completely charge-neutralized DNA, which is maximally associated with cationic bilayers. In these CLDCs, the DNA is completely protected from nucleases and intercalating dyes and possesses a net positive zeta
potential, suggesting that the exterior of the particles is composed
primarily of cationic lipids. These studies also agree with SAXS
results that describe lamellar repeat distances equivalent to the thickness of the lipid bilayer and a single DNA double helix
(10, 25). Because SAXS studies rely on correlations within ordered
repeating structures, however, they do not readily describe the
extended DNA structures on the surface of the negatively charged CLDCs
proposed in Fig. 10 and observed by cryo-EM (6).

View larger version (21K):
[in a new window]
Fig. 10.
Proposed models for the structural
arrangement of CLDCs prepared at different charge ratios or in the
presence of increased ionic strength as described under
"Discussion."
Incorporation of DOPE or DOPC into positively charged DOTAP CLDCs
results in similar values for the distance between DNA and the lipid
bilayer ranging from 18 to 21 Å, suggesting little effect of bilayer
charge density on the proximity of the DNA strands to the lipid. This
is in contrast to the effect membrane charge density has on the
interhelical spacing of DNA as observed by SAXS (10). Perhaps more
interesting is the fact that DOTAP:DOPE CLDCs show similar trends in
L compared with DOTAP CLDCs. Complexes of DOTAP:DOPE with
linear
-phage DNA have previously been shown to coexist as inverted
hexagonal and lamellar structures (15). In an inverted hexagonal
structure, a cylindrical distribution of acceptor molecules around the
DNA double helix would negate the averaging in the distance of HOC from
the lipid surface, resulting in a significant decrease in this distance
from 12.5 Å to effectively 0. Thus, a distance of closest approach of
HOC to BODIPY would be expected to be closer to ~12 Å. Because a
marked decrease in L is not observed for DOTAP:DOPE CLDCs
compared with DOTAP alone, the existence of nonlamellar phases is not apparent.
Studies with DDAB demonstrate a marked increase in the average distance of DNA from the bilayer. For negatively charged CLDCs, this distance is 7-17 Å greater than observed for DOTAP. For positively charged CLDCs, the value of L is 4 Å greater than that observed for DOTAP. In negatively charged CLDCs, the increased distance probably reflects the differences in the association of DNA on the particle surface (Fig. 10). Closer interhelical spacing of DNA because of the slight increase in charge density for DDAB compared with DOTAP (e.g. 1 charge/60 and 70 Å2, respectively) may further extend the unbound portion of DNA away from the surface. Alternatively, for positively charged complexes, it has been shown that DDAB does not cause the same degree of dehydration of DNA as DOTAP (17).
Increasing the ionic strength more dramatically perturbs the average distance between DNA and lipid in complexes prepared below charge neutrality. For negatively charged CLDCs, the increased average distance between DNA and lipid presumably results from the decreased association of DNA with the surface of the particle or extension of unbound regions of DNA away from the particle (Fig. 10). The reason for the lack of effect of ionic strength on the distance between DNA and lipid in positively charged CLDCs is unclear. The differential effect of increased ionic strength on positively and negatively charged CLDCs correlates with observed effects on DNA interhelical spacing observed using SAXS where the spacing increased slightly for negatively charged CLDCs but remained unchanged for positively charged complexes (14).
Correlations between the distance of DNA from the cationic bilayer and the hydrodynamic size of the complexes are mixed. For negatively charged complexes, it appears that the increased distance observed by FRET coincides with an increase in the hydrodynamic size of CLDCs containing only cationic lipids. This agrees with the model presented in Fig. 10 in which changes in L reflect changes in the association of DNA with the surface of the particles. In the case of positively charged CLDCs, no correlation between L and the hydrodynamic size is apparent. The much larger size of DDAB CLDCs in this charge regime probably reflects aggregation of complexes caused by the destabilization of the rigid DDAB bilayer. Reductions in particle size by fluidizing the DDAB bilayer upon incorporation of DOPE or cholesterol have been previously reported (17). For DOTAP CLDCs at higher ionic strength, the much larger size observed may also result from aggregation in this case caused by the reduced electrostatic repulsion between particles.
In conclusion, we have demonstrated the utility of FRET to define
structural features of CLDCs representing a variety of compositions. These studies support the multi-lamellar model of CLDCs observed by
SAXS and cryo-EM. Most significantly, this approach permits the
examination of these nonviral gene delivery complexes in the solution
state and at concentrations nearer physiologically relevant values
using equipment commonly available in most laboratories.
| |
FOOTNOTES |
|---|
* This work was supported by Valentis, Inc.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by the American Foundation for Pharmaceutical Education. Present address: Dept. of Immunology (IMM-19), The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037.
¶ Present address: Molecular Biophysics & Biochemistry Dept., Yale University, 260 Whitney Ave., P.O. Box 208114, New Haven, CT 06520-8114.
** To whom correspondence should be addressed: Dept. of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Ave., Lawrence, KS 66047. E-mail: middaugh@ku.edu.
Published, JBC Papers in Press, September 23, 2002, DOI 10.1074/jbc.M207758200
2 C. M. Wiethoff, M. L. Gill, G. S. Koe, J. G. Koe, and C. R. Middaugh (2002) J. Pharm. Sci., in press.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: CLDC, cationic lipid-DNA complex; cryo-EM, cryoelectron microscopy; SAXS, small angle x-ray scattering; FRET, fluorescence resonance energy transfer; DOTAP, 1,2-dioleoyl-3-trimethylammonium-propane; DDAB, dimethyldioctadecylammonium bromide; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; HOC, Hoechst 33258; BODIPY-PE, 2-(4,4-difluoro-5,7-diphenyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphoethanolamine; BODIPY-PC, 2-(4,4-difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Chadwick, S. L., Kingston, H. D., Stern, M., Cook, R. M., O'Connor, B. J., Lukasson, M., Balfour, R. P., Rosenberg, M., Cheng, S. H., Smith, A. E., Meeker, D. P., Geddes, D. M., and Alton, E. W. (1997) Gene Ther. 4, 937-942[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Waddill, W., III,
Wright, W., Jr.,
Unger, E.,
Stopeck, A.,
Akporiaye, E.,
Harris, D.,
Grogan, T.,
Schluter, S.,
Hersh, E.,
and Stahl, S.
(1997)
AJR Am. J. Roentgenol.
169,
63-67 |
| 3. | McLachlan, G., Ho, L. P., Davidson-Smith, H., Samways, J., Davidson, H., Stevenson, B. J., Carothers, A. D., Alton, E. W., Middleton, P. G., Smith, S. N., Kallmeyer, G., Michaelis, U., Seeber, S., Naujoks, K., Greening, A. P., Innes, J. A., Dorin, J. R., and Porteous, D. J. (1996) Gene Ther. 3, 1113-1123[Medline] [Order article via Infotrieve] |
| 4. | Nishikawa, M., and Huang, L. (2001) Hum. Gene Ther. 12, 861-870[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Zuidam, N. J., Hirsch-Lerner, D., Margulies, S., and Barenholz, Y. (1999) Biochim. Biophys. Acta 1419, 207-220[Medline] [Order article via Infotrieve] |
| 6. |
Xu, Y.,
Hui, S. W.,
Frederik, P.,
and Szoka, F. C., Jr.
(1999)
Biophys. J.
77,
341-353 |
| 7. |
Tarahovsky, Y. S.,
Rakhmanova, V. A.,
Epand, R. M.,
and MacDonald, R. C.
(2002)
Biophys. J.
82,
264-273 |
| 8. |
Smisterova, J.,
Wagenaar, A.,
Stuart, M. C.,
Polushkin, E.,
ten Brinke, G.,
Hulst, R.,
Engberts, J. B.,
and Hoekstra, D.
(2001)
J. Biol. Chem.
276,
47615-47622 |
| 9. |
Simberg, D.,
Danino, D.,
Talmon, Y.,
Minsky, A.,
Ferrari, M. E.,
Wheeler, C. J.,
and Barenholz, Y.
(2001)
J. Biol. Chem.
276,
47453-47459 |
| 10. |
Radler, J. O.,
Koltover, I.,
Salditt, T.,
and Safinya, C. R.
(1997)
Science
275,
810-814 |
| 11. |
MacDonald, R. C.,
Ashley, G. W.,
Shida, M. M.,
Rakhmanova, V. A.,
Tarahovsky, Y. S.,
Pantazatos, D. P.,
Kennedy, M. T.,
Pozharski, E. V.,
Baker, K. A.,
Jones, R. D.,
Rosenzweig, H. S.,
Choi, K. L.,
Qiu, R.,
and McIntosh, T. J.
(1999)
Biophys. J.
77,
2612-2629 |
| 12. | Lobo, B. A., Rogers, S. A., Choosakoonkriang, S., Smith, J. G., Koe, G., and Middaugh, C. R. (2002) J. Pharm. Sci. 91, 454-466[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Lobo, B. A., Davis, A., Koe, G., Smith, J. G., and Middaugh, C. R. (2001) Arch. Biochem. Biophys. 386, 95-105[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Koltover, I.,
Salditt, T.,
and Safinya, C. R.
(1999)
Biophys. J.
77,
915-924 |
| 15. |
Koltover, I.,
Salditt, T.,
Radler, J. O.,
and Safinya, C. R.
(1998)
Science
281,
78-81 |
| 16. |
Kennedy, M. T.,
Pozharski, E. V.,
Rakhmanova, V. A.,
and MacDonald, R. C.
(2000)
Biophys. J.
78,
1620-1633 |
| 17. |
Choosakoonkriang, S.,
Wiethoff, C. M.,
Anchordoquy, T. J.,
Koe, G. S.,
Smith, J. G.,
and Middaugh, C. R.
(2001)
J. Biol. Chem.
276,
8037-8043 |
| 18. | Solodin, I., Brown, C. S., Bruno, M. S., Chow, C. Y., Jang, E. H., Debs, R. J., and Heath, T. D. (1995) Biochemistry 34, 13537-13544[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Eastman, S. J., Siegel, C., Tousignant, J., Smith, A. E., Cheng, S. H., and Scheule, R. K. (1997) Biochim. Biophys. Acta 1325, 41-62[Medline] [Order article via Infotrieve] |
| 20. |
Mok, K. W.,
and Cullis, P. R.
(1997)
Biophys. J.
73,
2534-2545 |
| 21. | Gershon, H., Ghirlando, R., Guttman, S. B., and Minsky, A. (1993) Biochemistry 32, 7143-7151[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Huebner, S.,
Battersby, B. J.,
Grimm, R.,
and Cevc, G.
(1999)
Biophys. J.
76,
3158-3166 |
| 23. | Battersby, B. J., Grimm, R., Huebner, S., and Cevc, G. (1998) Biochim. Biophys. Acta 1372, 379-383[Medline] [Order article via Infotrieve] |
| 24. |
Schmutz, M.,
Durand, D.,
Debin, A.,
Palvadeau, Y.,
Etienne, A.,
and Thierry, A. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12293-12298 |
| 25. | Lasic, D. D., Strey, H., Stuart, M. C. A., Podgornik, R., and Frederik, P. M. (1997) J. Am. Chem. Soc. 119, 832-833[CrossRef] |
| 26. | Farhood, H., Serbina, N., and Huang, L. (1995) Biochim. Biophys. Acta 1235, 289-295[Medline] [Order article via Infotrieve] |
| 27. | Song, Y. K., Liu, F., Chu, S., and Liu, D. (1997) Hum. Gene Ther. 8, 1585-1594[Medline] [Order article via Infotrieve] |
| 28. | Birchall, J. C., Kellaway, I. W., and Mills, S. N. (1999) Int. J. Pharm. 183, 195-207[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Harries, D.,
May, S.,
Gelbart, W. M.,
and Ben-Shaul, A.
(1998)
Biophys. J.
75,
159-173 |
| 30. | Yguerabide, J. (1994) Biophys. J. 66, 683-693[Medline] [Order article via Infotrieve] |
| 31. |
Wolber, P. K.,
and Hudson, B. S.
(1979)
Biophys. J.
28,
197-210 |
| 32. |
Dewey, T. G.,
and Hammes, G. G.
(1980)
Biophys. J.
32,
1023-1035 |
| 33. | Baird, B., Shopes, R. J., Oi, V. T., Erickson, J., Kane, P., and Holowka, D. (1989) Int. Arch. Allergy Appl. Immunol. 88, 23-28[Medline] [Order article via Infotrieve] |
| 34. | Baird, B., and Holowka, D. (1985) Biochemistry 24, 6252-6259[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Shahrokh, Z.,
Verkman, A. S.,
and Shohet, S. B.
(1991)
J. Biol. Chem.
266,
12082-12089 |
| 36. | Shaklai, N., Yguerabide, J., and Ranney, H. M. (1977) Biochemistry 16, 5585-5592[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Fernando Valenzuela, C., Weign, P., Yguerabide, J., and Johnson, D. A. (1994) Biophys. J. 66, 674-682[Medline] [Order article via Infotrieve] |
| 38. | Zuidam, N. J., and Barenholz, Y. (1997) Biochim. Biophys. Acta 1329, 211-222[Medline] [Order article via Infotrieve] |
| 39. | Marsh, D. (ed) (1990) CRC Handbook of Lipid Bilayers , CRC Press, Boca Raton, FL |
| 40. | Okuyama, K., Soboi, Y., Iijima, N., Hirabayashi, K., Kunitake, T., and Kijayama, T. (1988) Bull. Chem. Soc. Jpn. 61, 1485-1490[CrossRef] |
| 41. | Johnson, I. D., Kang, H. C., and Haugland, R. P. (1991) Anal. Biochem. 198, 228-237[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Hirsch-Lerner, D., and Barenholz, Y. (1998) Biochim. Biophys. Acta 1370, 17-30[Medline] [Order article via Infotrieve] |
| 43. |
Wiethoff, C. M.,
Smith, J. G.,
Koe, G. S.,
and Middaugh, C. R.
(2001)
J. Biol. Chem.
276,
32806-32813 |
| 44. | Haas, E., Katchalski-Katzir, E., and Steinberg, I. Z. (1978) Biochemistry 17, 5064-5070[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Araki, T., Yamamoto, A., and Yamada, M. (1987) Histochemistry 87, 331-338[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Bandyopadhyay, S., Tarek, M., and Klein, M. L. (1999) J. Phys. Chem. B 103, 10075-10080[CrossRef] |
| 47. |
Podgornik, R.,
Rau, D. C.,
and Parsegian, V. A.
(1994)
Biophys. J.
66,
962-971 |
| 48. | Hirsch-Lerner, D., and Barenholz, Y. (1999) Biochim. Biophys. Acta 1461, 47-57[Medline] [Order article via Infotrieve] |
| 49. | Bhattacharya, S., and Mandal, S. S. (1998) Biochemistry 37, 7764-7777[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Crook, K., McLachlan, G., Stevenson, B. J., and Porteous, D. J. (1996) Gene Ther. 3, 834-839[Medline] [Order article via Infotrieve] |
| 51. | Ferrari, M. E., Nguyen, C. M., Zelphati, O., Tsai, Y., and Felgner, P. L. (1998) Hum. Gene Ther. 9, 341-351[Medline] [Order article via Infotrieve] |
| 52. | Crook, K., Stevenson, B. J., Dubouchet, M., and Porteous, D. J. (1998) Gene Ther. 5, 137-143[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Even-Chen, S., and Barenholz, Y. (2000) Biochim. Biophys. Acta 1509, 176-188[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
C. S. Braun, M. T. Fisher, D. A. Tomalia, G. S. Koe, J. G. Koe, and C. R. Middaugh A Stopped-Flow Kinetic Study of the Assembly of Nonviral Gene Delivery Complexes |